Andrew Penkethman – Managing Director and CEO – Ardea Resources (ASX:ARL) is advancing its flagship 100%-owned Kalgoorlie Nickel Project (KNP). KNP is the largest Nickel–Cobalt resource in Australia and in the top 10 globally, making it of a scale that is incredibly rare and important in the World’s journey to Net Zero. KNP was awarded Major Project Status by the Australian Federal Government, recognising the national and strategic significance of the KNP to the Australian economy and the Eastern Goldfields of Western Australia.
Copyright 2024 – Finance News Network
18 July 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz emphasise staying rooted in fundamentals and deliberately avoiding media-driven noise and panic
08 Nov 2023 - Hatch Managing Director of Australia and Asia Jan Kwak discusses key commodities, geographical opportunities, innovation, applying the circular economic model to mining, and the process of producing feasibility studies.
27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and the company's recent FDA approval.
27 Mar 2024 - Empire Energy Limited (ASX:EEG) CEO Alex Underwood discusses the implications of gas shortfalls across Australia and possible sources for new supply.
16 Sep 2024 - Quantum Brilliance CEO Mark Luo discusses how his company is pioneering quantum computing with synthetic diamonds, offering a miniaturised and energy-efficient alternative. He highlights the company's rapid growth since its spin-out from the Australian National University, its unique approach to quantum technology and the enormous commercial potential of quantum at the edge.
24 Nov 2020 - Imdex (ASX:IMD) Limited CEO Paul House discusses the company's financial update, outlook and strategy, and provides an introduction to its technology, which improves the productivity of drill rigs, data collection and analysis.
01 Jul 2021 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO & Managing Director Dr Michael Baker discusses the company's acquisition of the invariant natural killer T (iNKT) cell therapy platform from Imperial College London.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
